The hydrolases aminopeptidase A and dipeptidyl peptidase IV, both present in the kidney on the brush borders of the proximal tubule epithelial cells and podocytes, are involved in the induction of experimental membranous glomerulonephritis in the mouse. However, little is known about their (co)distribution in other tissues and their function in health and disease. A detailed insight into the localization of these two enzymes is a prerequisite to elucidation of their function. Therefore, we investigated the presence and co-distribution of aminopeptidase A and dipeptidyl peptidase IV by immunohistology with two different rat monoclonal antibodies, the specificity of which was determined by an immunodepletion technique. In addition, the molecular weight of the hydrolases was analyzed by SDS-PAGE after
Introduction
Antibodies that interact with intrinsic antigens on podocytes can induce a membranous glomerulonephritis, which can be used as an experimental model for the human form of this disease (1, 2) . One of these antigens which has extensively been studied in the rat is the Heymann antigen (3) (4) (5) . However, this antigen is not present on mouse podocytes and is therefore not involved in the development of membranous glomerulonephritis in this species (6) . We have found that two other antigens present on podocytes, i.e., the hydrolases aminopeptidase A (APA; EC 3.4.11.7) and dipeptidyl peptidase IV (DPP IV; EC 3.4.14.5), can participate as targets in the induction of a passive membranous glomerulonephritis in the mouse (6) (7) (8) (9) . Both enzymes have also been reported to be involved in other experimental and human forms of nephropathy, such as the renal ablation model (lo), passive anti-DPP IV nephritis (11) (12) (13) , Heymann nephritis (14) (15) (16) in the rat, lupus nephritis in the mouse (17, 18) , and glomerulosclerosis (19) , diabetic nephropathy (20) . and chronic interstitial nephritis (21, 22) in humans.
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Correspondence ta S. Mentzel isolation by solid-phase immunoprecipitation from glomeruli, renal brush borders, and thymus. Both hydrolases showed different molecular weights in renal corpuscle, renal brush borders, and thymic cells. A widespread organ distribution of the two hydrolases was observed, with co-localization in kidney, liver, small intestine, thymus, brain, spleen, and lymph nodes, either on the same cells or on different cells in the same organ. This distribution and partial co-localization suggests that the two hydrolases, acting either alone or in concert, have a role in many diverse biological processes. (J Histochem Cytochem 44:445461, 1%) Both APA and DPP IV are cell membrane-bound hydrolases, assumed to be involved in diverse biological processes such as peptide degradation (23,24) and Band T-cell differentiation (23.25). Previous studies have shown that APA and DPP IV are also present on various cell types of many organs other than the kidney. Therefore, studies on the organ distribution of APA have been carried out in the rat and mouse with enzyme histochemical methods (26,27) and on a restricted number of organs in the mouse with a monoclonal antibody (MAb) against the BPllbC3 antigen which was recently identified as APA (28). The organ distribution of DPP IV has been examined in a more or less restricted way in the mouse, rat, and rabbit by enzyme histochemistry (29) or immunohistology using MAbs (13, 30, 31) . Previously, we studied the localization of DPP IV in the mouse with polyclonal antibodies (6, 8, 31 ) that may lack the ultimate specificity of MAbs. In our laboratory we have generated a panel of rat MAbs to different antigens present on podocytes, several of which were directed to APA and DPP IV. For this study we selected two clones, ASD-4 and ASD-36. which bind respectively to APA and DPP IV (7) . These two MAbs enabled us to study more thoroughly the organ distribution and putative co-localization of APA and DPP IV in the mouse. Because the functional roles of the two enzymes are largely unknown, we studied the organ distribution of APA and DPP IV, thus looking in greater detail at their distribution in kidney and thymus.
Materials and Methods
Animals. Balblc and Balblc, nulnu mice were originally obtained from the Jackson Laboratory (Bar Harbor, ME) and were kept in the breeding farm facility of the Central Laboratory of Animals of our university by continuous brother-sister matings. Male Lou rats used for the production of MAbs were obtained from Harlan Olac (Blackthorn, Bicester, UK).
Preparation of Solubilized Suspensions from Renal Brush Borders, Renal Corpuscles, and Thymus. An enriched suspension of mouse renal brush border membrane vesicles from proximal tubule epithelial cells was prepared from Balblc kidneys according to the method of Malathi et al. (32) . using a 2-mM Tris-HC1 buffer, pH 7.2, containing 50 mM mannitol, the protease inhibitors EDTA (20 mM), PMSF (1 mM), benzamidine (1 mM), Trasylol (10 U/ml), and 0.02% NaN3 as described (7) . The brush border suspension was solubilized with 2% Triton X-114 in 50 mM Tris-HCI at 4'C for 30 min and subjected to Triton X-114 phase separation at 37°C for 20 min. followed by centrifugation at 300 x g for 5 min (33). The obtained brush border preparation enriched in integral membrane proteins served as immunogen for the production of MAbs. In the immunoprecipitation procedure, a brush border fraction was used that was solubilized with 1% sodium deoxycholate (brush border Doc) in 50 mM Tris-HC1, pH 8.5, with protease inhibitors and was subsequently centrifuged at 100,000 x g for 1 hr at 4'C. For the fluorimetric enzyme assay, brush border membrane vesicles were solubilized for 30 min at 4'C with 1% Doc in 50 mM Tris-HCI, pH 8.5, without protease inhibitors. Renal corpuscles were isolated from kidneys of young Balblc mice as previously described (34). The kidneys were perfused with ferric oxide and subsequently pushed through a 90-pm pore size stainless steel sieve, after which the renal corpuscles were separated from other renal components with a magnet. The highly enriched renal corpuscle suspension, containing <5 % tubule or vascular fragments, was solubilized in 1% Doc and used in the immunoprecipitation. A complete thymus from a young Balblc mouse was solubilized in 1% Triton X-100. This preparation of solubilized thymic antigens was used in the immunoprecipitation technique. Protein concentrations were determined by the method of Lowry (35) .
Monoclonal Antibodies to APA and DPP IV. Male Lou rats were immunized IP with the detergent phase of the Triton X-114 extract of mouse brush border preparation, as described (7) . Spleen cells from the Lou rats were fused with SP 210 mouse myeloma cells by the procedure of Kohler and Milstein (36) . Hybridomas were grown in 96-well tissue culture plates (Costar; Cambridge, MA) with HEPES-buffered RPMI-1640 culture medium (MA Bioproducts; Bethesda, MD), containing 10% decomplemented fetal calf serum, gentamicin (40 pglml), 1 mM L-glutamine, 1 mM sodium pyruvate. and 10% supernatant of a human umbilical vein cell culture, supplemented with HAT. Hybridomas were selected for production of antibodies to antigens present on both brush border membrane and podocytes by indirect immunofluorescence (IF) on acetone-fixed cryostat sections from normal mouse kidneys. Selected hybridomas were cloned several times by limiting dilution until all subclones showed the same reactivity pattern in the indirect IF screening procedure. Ascites containing MAbs was subsequently produced in Balblc. nulnu mice, and was purified by ammonium sulfate precipitation. The MAbs coded ASD-4 and ASD-36 were selected for this study. The IgG content of the MAb preparations was measured by radial immunodiffusion (37). IgG subclasses were determined with an isotyping kit for rat MAbs according to the instructions of the manufacturer (Serotec; Oxford, UK). The test system is based on rat cell agglutination with highly specific antibodies directed to isotypes of rat IgG attached to sheep erythrocytes (38).
Immunoprecipitation. By a solid-phase immunoprecipitation procedure (39). APA and DPP IV were isolated from suspensions of detergent solubilized renal corpuscles (1% Doc), brush border vesicles (1% Doc), and thymus (1% Triton X-100) and were analyzed by SDS-PAGE. All three fractions were radiolabeled with ''>I (Amersham; Buckinghamshire, UK) using iodobeads (Pierce Chemical; Rockford, IL) as a coupling reagent (40). Free was removed by Sephadex G-25 chromatography. Polystyrene microtiter plates (Costar) were precoated with 10 pglwell affinity-purified goat anti-rat Ig antibodies (Cappel-Organon Teknika; Boxtel, The Netherlands) in PBS for 18 h at 4°C. After five washes with PBS containing 0.05% Tween, the wells were coated with 100 pllwell of purified ascites containing 10 mg Ig/ml of MAb for 3 hr at 37°C. After five further washes the wells were blocked for 3 hr at 21' C with PBS containing 1% BSA and 1% normal rat serum, and then again washed five times. The wells were next incubated for 2 hr at 21' C with the '251-labeled kidney or thymic suspensions. The wells were then washed 10 times with immunoprecipitation (IP) buffer (150 mM NaCI, 50 mM Tris, 5 mM EDTA, 0.1% Triton X-100, 0.02% SDS. 10 U/ml Trasylol, 1 mM PMSF, and 1 mM benzamidine; pH 7.4). Next, 100 pllwell of reducing (2.3% SDS, 200 mM dithiothreitol, 10% glycerol, 60 mM Tris-HCI, pH 6.8) or nonreducing (2.3% SDS, 10% glycerol, 60 mM Tris-HC1, pH 6.8) SDS sample buffer was added, after which the wells were incubated for 15 min at 60°C and then for 5 min at 100°C. The immunoisolated proteins were analyzed by SDS-PAGE in 7.5% acrylamide according to Laemmli (41) . For autoradiography, the gels were dried and exposed at -7O'C with preflashed X-ray film (Kodax X-Omat).
Fluorimetric Enzyme Assay. The specificity of ASD-4 for APA and ASD-36 for DPP IV was determined by a solid-phase immunodepletion procedure as described (7, 42) . The purified MAb was first coupled to cyanogen bromide-activated Sepharose 4B (S4B) according to the instructions of the manufacturer (Pharmacia; Uppsala, Sweden). Briefly, 5 mg of the selected MAb in 1 ml of 0.1 M carbonate buffer, pH 8.4, containing 0.5 M NaCI, was added per ml of S4B. Residual binding sites were saturated with 1 M ethanolamine. A brush border suspension solubilized in 1% Doc containing 4 mg protein was dissolved in 5 ml buffer (20 mM Tris-HCI, pH 8.4, containing 0.1% Doc) and was incubated for 17 hr at 4°C under constant stirring with 1 ml of S4B coupled with MAb. In a control experiment, a brush border solution was incubated with S4B beads to which no MAb had been coupled. The supernatant was removed and the beads were washed several times with buffer. Elution of the antigen bound to 1 ml of beads was performed with 5 ml of 50 mM diethylamine containing 0.1% sodium deoxycholate, pH 11.5, for 5 min. The eluted proteins were neutralized with 2 M Tris, pH 7.4. The enzymatic activities for APA, DPP IV, and APN were measured fluorimetrically in the control brush border-Doc solution, the immunodepleted solution, and the eluate, using L-glutamic acid-a-7amido-4-methylcoumarin (Glu. AMC), glycyl-~-proline-7-amido-4-methylcoumarin-HBr (Gly.Pro.AMC; both from Bachem, Bubendorf, Switzerland), and ~-alanine-7-amido-4-methylcourmarin (Ala.AMC; from Serva, Heidelberg, Germany) as specific and sensitive substrates for APA. DPP IV, and APN. respectively (43) . For determination of APA activity, the three fractions and the substrates were solubilized in 0.1 M Tris-HCI buffer containing 1.25 mM CaC12, pH 7.0. For APN activity, 0.1 M Tris-HCL buffer, pH 7.0, and for DPP IV activity 0.1 M Tris-HC1 buffer, pH 8.0, were used as solutions. Ten p1 of one of the three fractions was incubated with 100 pI of one of the three substrates (2,10-* M) for 20 min at 37°C. The reaction was stopped by addition of 890 p1 of 0.2 M Tris-NaOH, pH 11. The enzyme activities were determined by the fluorescence of 7-amino-4-methylcoumarin cleaved from the substrates (43) . The fluorescence was measured at 375 nm (excitation) and 440 nm (emission) using a luminescence spectrometer (LS5; Perkin Elmer. Norwalk, CT). The enzyme activities of the various fractions are expressed as nkatallml, 1 nkatal being the amount of enzyme that converts 1 nmol of substratelsec under the given assay conditions, or as percentages of the activities present in the control brush border solution.
Indirect Immunofluorescence. Because in preliminary studies we had found no differences in the localization of both hydrolases between male and female mice, except for the reproductive organs, we present the localization found in male mice. Fragments of organs from a 2-month-old male Balblc mouse, as listed in Table 1 . were snap-frozen in liquid nitrogen. For indirect IF of the female reproductive organs, a 2-month-old female Balblc mouse was used. Two pm-thick. acetone-fixed cryostat sections were inccbated with MAbs ASD-4 and ASD-36 for 30 min at room temperature.
Binding of the two MAbs to the various tissues was visualized with FITClabeled goat anti-rat IgG containing 1.5% normal mouse serum (Cappel-Organon Teknika). We differentiated in some organs the presence of both hydrolases from B-cells or endothelial cells by additional double labeling experiments in which incubation of ASD-4 or ASD-36 was followed by incubation of TRITC-labeled goat anti-mouse Ig for identification of B-cells or of the TRITC-conjugated lectin GsrfJbniu simplzcifoliu (Sanbio; Uden, The Netherlands), which identifies specifically mouse endothelial cells (44) . To define more precisely in the thymus the presence of APA, sections were double labeled with ASD-4 (APA) and a mouse MAb to cytokeratin 2/8 (RCK 102) (45) . The thymic sections were first incubated with ASD-4 diluted 1:100 in PBS/l% BSA, washed, and incubated with FIE-labeled goat anti-rat IgG diluted 1:25. After this binding the sections were preincubated with rabbit anti-mouse IgG diluted 1:lOO in PBS/l% BSA, followed by a short wash in PBS. The sections were then incubated with an MAb against cytokeratin and washed again in PBS. TRITC-labeled rabbit anti-mouse IgG (In< Diagnostics; Uithoorn, The Netherlands) was diluted 1:100 in PBS/1% BSA, and washed in PBS. All sections were embedded in Aquamount (BDH Chemicals, Poole, UK), and examined in a fluorescence microscope equipped with Ploemopak Epi-illumination (Leitz; Wetzlar, Germany). The staining intensity was recorded semiquantitatively on a scale from 0 to 4 + , as described previously (9) . Enzyme Histochemistry. To correlate the localization of APA and DPP IV protein in the kidney and thymus with their enzymatic activities, we examined the enzymatic activities with specific substrates by the enzyme histochemistry technique. For enzyme histochemistry, a kidney and a thymus from a young Balb/c mouse were removed and snap-frozen in liquid nitrogen. For demonstration of APA and DPP IV activity, 5 pm-thick, acetone-fixed sections were incubated for 10 min for the kidney and for 30-45 min for the thymus at 37°C in substrate buffer containing 100 mM Tris-HCI, pH 7.0, 2 mM CaC12, 1.1 mM Fast Blue salt (Serva) 1.6 mM L-glutamic acid-a-methoxy-B-naphtylamide for APA, or 1.6 mM glycyl-L-prolinea-methoxy-8-naphtylamide for DPP IV (Bachem). After rinsing with PBS, the sections were embedded in Aquamount and examined by conventional light microscopy.
Immunoelectron Microscopy. The localization of APA and DPP IV in a restricted number of organs, i.e., kidney, liver, small intestine, thymus, and lung of a normal Balb/c mouse, was examined by indirect immunoelectron microscopy (IEM) using immunoperoxidase labeling on 20-pm frozen sections. A Balbk mouse was first perfused retrogradely via the aorta with PBS for 5 min and subsequently with a mixture of 10 mM periodate, 75 mM lysine, and 2% paraformaldehyde, pH 6.2 (PLP) for 10 min (6). The organs selected for IEM were removed and small pieces were further fixed by immersion for an additional 3 hr in PLP. After rinsing several times in PBS, the fragments were cryoprotected by immersion in 2.3 M sucrose, pH 7.2, for 1 hr, and then frozen in liquid nitrogen. Twenty pm-thick sections were rinsed in PBS for 1 hr, then incubated with MAbs ASD-4 and ASD-36 diluted in PBS containing 1% BSA for 18 hr at 4"C, followed, after several washes with PBS, by incubation for 1.5 hr with a peroxidase-labeled rabbit anti-rat IgG diluted in PBS containing 1% BSA and 2% normal mouse serum. After three washes in PBS, the sections were incubated in PBS, pH 7.4, containing diaminobenzidine (DAB) medium for 10 min, followed by DAB with addition of 0.003% H202 for 7 min. The sections were washed in distilled water, postfixed in palade buffer containing 1% Os04 for 30 min at 4°C. dehydrated, and embedded in Epon 812. Thin sections were prepared on a LKB ultratome (LKB Instruments; Bromma, Sweden) and examined by electron microscopy @OL 1200 EXZ;FOL, Tokyo, Japan).
Results

Characterization of the MAbs
The two rat MAbs that were selected for this study, ASD-4 and ASD-36, were of the IgG: and IgG2b subclass, respectively (7) . The molecular weights of the antigens isolated by the MABs in the solid phase immunoisolation technique on radiolabeled preparations of renal corpuscles, renal brush borders ( Figure I ). An additional low molecular weight-protein of 43 KD was precipitated by both ASD-4 and ASD-36 from the thymus (Figure 2 , Lane 2). renal corpuscles, and renal brush borders (data not shown). The protein recognized by ASD-36 is most probably the enzyme adenosine deaminase (43, and the band isolated by ASD-4 is actin that co-precipitated with APA (48). These immunoprecipitation experiments show that there are differences in molecular weight of APA as well as DPP IV from different organs (kidney vs thymus), and from different structures within the same organ (renal corpuscles vs brush borders).
Specijcity of the MAbs
The specificity of the MAbs for the brush border hydrolases APA and DPP IV was determined by an immunoadsorption procedure using Sepharose-4B beads coated with either ASD-4 or ASD-36 MAb. Enzymatic activities for APA, DPP IV, and aminopeptidase N (APN; EC 3.4.11.2) detected in the sodium deoxycholate (Doc) solubilized brush border fraction using specific substrates in the fluorimetric assay were 5.3, 17.1, and 50.7 nkatal, respectively. The APA activity was selectively depleted from the brush border-Doc solution by ASD-4 (3%), whereas DPP IV activity was selectively depleted by ASD-36 (3%) ( Figures 3A and B) . In both cases, the activities for the other two enzymes remained unaltered. Subse- 
Organ Distribution of APA and DPP IV
By indirect IF and IEM. both APA and DPP IV showed a widespread organ distribution, as summarized in Table 1 . In some organs the two enzymes were located on the same cells, such as in the cortex of the kidney (Figures 4A and B ). small intestine ( Figures  10A and 10B ). liver ( Figures 10E and 10F ). various glands, visceral yolk sac of the placenta, choroid plexus of the eye ( Figure 12F ). and perineurium. In other organs the enzymes were present in separate segments of the same epithelium, such as in the uterus, with DPP IV predominantly being localized on the inner lining of the uterus and APA more on the ductal side of the epithelium (Figures  121 and 12J ). On the other hand, APA and DPP IV were present on separate cells in the thymus (Figures 8 and 9 ). brain ( Figures  12A and 12B) . and spleen and lymph nodes ( Figures 12C and 12D) .
In contrast to DPP IV, APA was also found in almost all organs on the endothelial cells of capillaries (Figures 4C, SC , IOC, and 12A). but not of arteries and veins, although sometimes a heterogeneous distribution was seen, such as in the kidney (Figures 4 A  and 4C ). In addition, APA could be found on smooth muscle cells of the media of arterioles ( Figure 12C ). DPP IV, however. was present on cells ofserosal cavities ( Figure 11D ). cells in fibrous capsules around many organs, and astrocytes in cerebrum and spinal cord ( Figure 12B ). In the kidney, APA and DPP IV are co-expressed mainly on identical cells in the cortex, but not in the medulla. In the glomerulus, both enzymes are located on the cell membranes of the podocytes, but not on the endothelial or messangial cells as seen by indirect IF and !EM (Figures 4A, 4B. 5A. and 6A) . The enzymes were also present on the brush borders of the proximal tubule cells, i.e., APA predominantly on the convoluted parts (SI and S2). whereas DPP IV was present along the entire proximal tubule (Figures 4A. 4B,  5B. and 68) . In contrast to DPP IV, APA was observed on the juxtaglomerular granular cells, the cells of the arteriolar media, and endothelial cells of the peritubular capillaries, especially of the each other and were both found on cortical epithelial cells ( Figures  8C, and 8D ). APA was not present on cells in the medulla ( Figure  8A ). DPP IV was present on cells in the medulla ( Figure 8A ). DPP ASDQ A. medulla ( Figures 4C and 5B ). DPP IV, on the other hand, was found on the cells of Henle's loops, as demonstrated by a double labeling IF procedure and by IEM ( Figures 4D and 6C ). The localization of APA and DPP IV. as revealed by immunohistology with ASD-4 and ASD-36, respectively, matched the enzymatic activities as demonstrated by enzyme histochemistry using specific substrates (Figure 7) . In contrast to the co-localization of APA and DPP IV in the kidney, there was clearly a different expression of the two hydrolases on cells in the thymus, spleen, and lymph nodes, suggesting different functions related to the development of thymocytes and activation of the T-cells (Figures 8, 12C , and 12D). APA was expressed only on cortical epithelial cells of the thymus, as confirmed in a double labeling experiment with an MAb specific for cytokeratin 218, which is present only on thymic epithelial cells ( Figures  8A and 8B ). APA expression, as demonstrated by ASD-4, and its enzymatic activity, as shown by enzyme histochemistry, matched IV was present on thymocytes, as shown by immunohistological staining with ASD-36 and enzyme histochemistry ( Figures 8E and  8F) . The expression of DPP IV varied from cortex to medulla, with higher expression in the thymic cortex, corresponding to earlier reports (49) . IEM with ASD-4 showed staining of the cell membranes of the cortical epithelial cells with its finger-like cell protrusions interdigitating between surrounding thymocytes ( Figure 9A ). ASD-36 stained all thymocytes, as shown in Figure 9B . In the peripheral lymphoid organs, DPP IV was found on T-cells and not on B-cells, as examined by double labeling with antibodies to IgM. In the spleen these T-cells were located around arterioles, which showed the presence of APA on the smooth muscle cells ( Figures  12C and 12D) .
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Both APA and DPP IV were abundantly co-expressed on the brush borders of the small intestine, which diffusely stained with ASD-4 and ASD-36, respectively, by indirect IF (Figures 10A and  10B ), and IEM ( Figure 11C ). The same co-expression was observed in the liver, in which APA and DPP IV were present in various amounts on sinusoidal lining cells, bile canaliculi and, to a lesser extent, on hepatocytes ( Figures 10E and 10F) . Their localization was more clearly demonstrated by indirect IEM (Figures 11A and  11B) . In the lung, as in most other organs, APA was present on the endothelial cells of the alveolar walls. In addition, it could be seen on the large Type I1 alveolar cells, but not on the smaller Type I alveolar cells ( Figures 1OC and 11E ). DPP IV was mainly located on Type I cells ( Figures 10D and 11F ). In the brain and spinal cord, APA was present only on endothelial cells of the capillaries, whereas DPP IV was shown on astrocytes ( Figures 12A and 12B ). Prominent staining with ASD-4 was also seen on follicle cells of the ovary and, to a lesser extent, on the cornea (Figures 12K and 12E ). Finally, DPP IV could be found on cells of the islets of Langerhans ( Figure 12H ), the epithelium of the Harderian gland of the eye, and the germinal epithelium of the ovary.
Discussion
This study examined the presence of two important hydrolases, APA and DPP IV, in organs of the mouse. This pattern of localization might enable us to provide more insight into the various biological functions that are attributed to them. APA and DPP IV are wellknown differentiation markers of lymphoid and myeloid progenitors and are believed to participate in stromal cell-dependent , Band T-cell differentiation and in T-cell activa.tion (23,24,50). In general, two ill-defined processes are related to the functions of these two enzymes. First, both hydrolases are involved in degradation and uptake of peptides by epithelial cells, such as the cells of the renal proximal tubules and the small intestine. Second, by breaking down ligands such as peptide hormones, growth factors, cytokines, or other regulatory proteins involved in cell activation, growth, and differentiation, APA and DPP IV can reduce or limit the cellular response induced by these ligands. It is in this second field that some progress has been made in recent years.
APA is a disulfide-linked homodimer that could easily be im- 
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munoprecipitated from the kidney and the thymus by ASD-4. The different molecular weights of APA isolated in this study from renal corpuscles, renal brush borders of proximal tubule epithelial cells, and thymus are not the products of different APA isoforms but probably reflect differences in glycosylation. Several arguments support this presumption. First, the isolated mouse cDNA sequence predicts a Type 11,945-amino-acid, integral cell membrane-bound protein of about 108 KD with a large extracellular domain, containing nine possible N-glycosylation sites (51) . Second, incubation of APA with glycolytic enzymes also yielded an identical protein backbone of almost 110 KD (52) (personal observation). Third, Northern blotting experiments on poly A' RNA from different mouse organs always showed a single hybridizing band of approximately 4 K B (28). APA has a short-18-amino-acid cytoplasmic tail that is covalently coupled to actin. as reported by us (48, 51) , indi-cating a role of actin in the transport of APA in various cells. APA digests N-terminal glutamyl and aspartyl residues from peptides (53) . APA that is expressed on early B-cells and on stromal cells in the bone marrow has an incompletely defined function in early B-cell development (51,54.55) . One of the best known functions of APA is its regulatory effect on the renin-angiotensin system, since APA converts angiotensin 11, the most active component of this system, into angiotensin I11 by removal of the N-terminal aspartyl residue (56) . Angiotensin I1 has several effects on the cardiovascular system by its vasopressor and growth-promoting actions. The hemodynamic effects in the kidney are related to its regulatory role of the renal blood flow, glomerular filtration rate, sodium reabsorption in the proximal tubules, and induction ofcell growth and hypertrophy of epithelial and muscle cells (57) . All of these effects are mediated by its binding to several receptors (58.59) . It shown that the hemodynamic effects of angiotensin I1 are regulated via the AT1 receptor (60) . In the kidney, the presence of the AT1 receptor is closely associated with the presence of APA, i.e., the glomerulus, the juxtaglomerular cells, the proximal tubule epithelial cells, the endothelial cells of the peritubular capillaries, and the arteriolar smooth muscle cells. This supports a regulatory role for APA on the actions of angiotensin I1 in the kidney. Recently, we have found evidence for this in an anti-APA-mediated glomerulonephritis in the mouse (7) . A single IV injection of ASD-4, an MAb that can block the enzymatic activity after binding to APA, induces an acute albuminuria that is not dependent on well-known systemic mediators, such as complement, platelets, fibrin, neutrophils, or monocytes. Treatment with the angiotensin-converting enzyme inhibitor enalapril and the AT1 receptor antagonist losartan considerably reduced this albuminuria, strongly indicating a role of angiotensin I1 in this model (61) . We presume that blocking of the glomerular APA activity causes a prolonged effect of angiotensin I1 on the glomerular hemodynamics or glomerular filter, leading to enhanced permeability for proteins. A function of APA in several forms of chronic nephropathy is also suggested by others who found an association between the extent of the glomemlar lesions and the reduction of the APA activity as determined by enzyme histochemistry (22). DDP IV is a heterodimer composed of two noncovalently linked, structurally related subunits that could be immunoprecipitated by ASD-36 from the kidney and thymus. The different molecular weights ranging from 103 to 116 KD, as analyzed in SDS-PAGE under reducing conditions, largely correspond with the state of glycosylation, as reported (62) . The assumption that differences in glycosylation are the basis for the differences in molecular weight of DPP IV is supported by the fact that only a single protein can be precipitated from thymus and kidney (63.64) . which is encoded by a single cDNA and can be digested with glycolytic enzymes, resulting in the predicted 87.5-KD protein backbone (23.50). This is also supported by the fact that only a single DPP IV RNA isoform has been identified in kidney and thymus (62) . Nevertheless, it has been described that a different cDNA coding for a variant DPP IV isoform (DPPX-L) has been cloned from bovine brain, but this iso- form is expressed predominantly in brain (65) . Mouse DPP IV cDNA predicts a Type 11, 760-amino-acid, membrane-bound glycoprotein with a calculated site of 87 KD and with a large extracellular and a shorncytoplasmic domain (62) . It is a multifunctional molecule involved in signal transduction, hydrolysis and uptake of peptides, and cell adhesion. DPP IV is a serine proteinase that N-terminally digests peptides and proteins with penultimate proline or alanine residues (66). DPP IV is known to hydrolyze many natural proline-containing peptides such as cytokines, growth factors, hormones, neurotransmitters, and vasoactive components, indicating its important role in regulatory processes. Many brain, kidney, and intestinal peptides contain a penultimate proline or alanine residue that makes them susceptible to hydrolysis (23.24). Like APA, DPP IV participates in the final degradation and uptake of prolinecontaining peptides in the renal proximal tubules and small intes-tine. The necessity of intact DPP IV activity in this process was nicely demonstrated in the Fischer 344 rat strain, which lacks functional DPP IV and shows reduced digestion of proline-containing peptides in kidney and small intestine (67) . DPP IV was originally known as a T-cell differentiation marker designated as CD26. It is the only ectoentyme that functions as a co-signaling molecule in the process of T-cell activation and proliferation (68) . For the signaling function, the enzymatic activity of DPP IV is not required (69) . DPP IV. however, is unable to stimulate T-cells by itself but requires the expression of the T-cell receptor (TCR)/CD3 complex (70) . DPP IV may also function as an auxiliary adhesion molecule, because it can bind with low affinity to the extracellular matrix components fibronectin and collagen (14, 71) . Recently, a role for DPP IV in the uptake of the human immunodeficiency virus in CD4' T-cells has been proposed (72) . Finally, DPP IV appears to participate in some forms of membranous glomerulonephritis in the mouse and rat (6.8.11-14,16,73,74) . However, in contrast to the well-defined role of APA in the passive glomerulonephritis in mice, the involvement of DPP IV in several experimental forms of glomerulonephritis is controversial at the moment and is not well understood. Using polyclonal and monoclonal anti-mouse DPP IV antibodies, we could induce a membraneous glomerulonephritis morphologically characterized by granular immune deposits in the subepithelial space of the glomerulus and without the involvement of systemic mediators. However, we never could induce a sustained enhanced glomerular permeability as seen in our anti-APA model or in the Heymann nephritis model in the rat. In the membranous glomerulonephritis in the so-called graft-vs-host mice, it was suggested that DPP IV was also involved in the formation of the immune complexes in the glomerulus, but we could not confirm this observation (17, 18, 75) . Moreover, the participation of this enzyme as an additional antigen next to the Heymann antigen in the induction of the Heymann nephritis is controversial (15, 76) . The function of DPP IV in the glomerulus is not fully understood at present. It is also not known whether DPP IV acts as an ectoenzyme or as an adhesion molecule in the various forms of glomerulonephritis.
In the thymus, APA is localized on cortical epithelial cells, whereas DPP IV is present on thymocytes. It is known that progenitors of T-lymphocytes develop into mature T-cells characterized by a rearranged T-cell receptorKD3 complex and the CD4 or CD8 molecules, by interacting with a variety of stromal or epithelial cells that compose the microenvironment of the thymus (77) . It is believed that these stromal cells in the thymic cortex provide specific signals in the T-cell differentiation that starts beneath the subcapsular region and evolves along the cortex to the medulla. Epithelial cells with their cytoplasmic extensions are organized in an elaborate network along which the thymocytes migrate during the differentiation process. How these stromal cells act on the development of T-cells is not well understood, but it is assumed that cellassociated MHC antigens play an important role in this process of maturation, requiring a direct contact between thymocytes and stromal cells. The cortical thymocytes that show high CD4'/8' expression and no or low TCR expression are submitted to an MHCrestricted "positive" selection and a tolerance-inducing "negative" selection before they become a mature T-cell population that recognizes peptides only in the context of self (77) (78) (79) . Which role APA plays in the maturation of thymocytes is completely unknown at the moment. DPP IV in the thymus is known as a co-stimulatory molecule of thymocytes, possibly in association with other activating factors such as IL-2 and CD4 or CD8 (64~30). Although the strict separation in expression of APA and DPP IV suggests some form of counteractive enzymatic activity between the cortical epithelial cells and thymocytes, such an effect remains to be confirmed. 
